netFormulary NHS
Sunderland Joint Formulary
NHS Sunderland Clinical Commissioning Group
South Tyneside and Sunderland NHS Foundation Trust
 Search
 Formulary Chapter 13: Skin - Full Chapter
13.02.02  Expand sub section  Barrier preparations
Medi Derma-S barrier cream (Medi Derma-S® barrier cream)
View adult BNF View SPC online
First Choice
Green

28, 90g

 
Medi Derma-S barrier film (Medi Derma-S ®barrier film)
View adult BNF View SPC online
First Choice
Green

Medi Derma-S non-sting barrier film foam 1ml applicator 61076 Medicareplus internatioal LTD) 5 device

Medi-derma-s non-sting medical barrier film aerosol 60819 (Medicareplus International Ltd) 50ml, 

 
Metanium ointment Barrier preparation (Metanium®)
View adult BNF View SPC online
Second Choice
Green

30g

 
   
Medi Derma-Pro Foam & Spray Skin Cleanser And Skin Protectant Ointment (Medi Derma-Pro Foam & Spray Skin Cleanser® )
View adult BNF View SPC online
Second Choice
Green

Medi-Derma-Pro Foam & Spray incontinence cleanser 63582 (Foam Medicareplus international Ltd) 250ml

 
   
Cavilon Advanced Skin Protectant (Cavilon®Film)
View adult BNF View SPC online
Third Choice
Green

Advanced liquid dressing (3M Health Care Ltd) 2.7ml

92g

 
   
Siopel cream  (Siopel®)
View adult BNF View SPC online
Third Choice

50g

 
   
Sudocrem (Sudocrem®)
View adult BNF View SPC online
Third Choice
Green

30g, 60g, 125g, 250g

 
   
Deegan’s ointment
( View adult BNF View SPC online
Third Choice

For use on neonatal and paediatric wards only

 
   
Sucralfate 4% cream
( unlicensed )
View adult BNF View SPC online
Formulary
Red

For limited use around gastrostomies when wound breakdown is thought to be aggravated by leakage of gastric acid

 
   
 ....
 Non Formulary Items
Barrier preparation  (Conotrane®)

View adult BNF View SPC online
Non Formulary
 
Barrier preparation  (Medicaid®)

View adult BNF View SPC online
Non Formulary
 
Barrier preparation  (Morhulin®)

View adult BNF View SPC online
Non Formulary
 
Barrier preparation  (Silicone barrier cream)

View adult BNF View SPC online
Non Formulary
 
Barrier preparation  (Sprilon®)

View adult BNF View SPC online
Non Formulary
 
Barrier preparation  (Vasogen®)

View adult BNF View SPC online
Non Formulary
 
Sorbaderm®

View adult BNF View SPC online
Non Formulary
 
Zinc and Caster Oil Ointment BP

View adult BNF View SPC online
Non Formulary
 
Zinc Cream BP

View adult BNF View SPC online
Non Formulary
 
Zinc Ointment BP

View adult BNF View SPC online
Non Formulary
 
  
Key
note Notes
Section Title Section Title (top level)
Section Title Section Title (sub level)
First Choice Item First Choice item
Non Formulary Item Non Formulary section
Restricted Drug
Restricted Drug
Unlicensed Drug
Unlicensed
Track Changes
Display tracking information
click to search medicines.org.uk
Link to adult BNF
click to search medicines.org.uk
Link to SPCs
Cytotoxic Drug
Cytotoxic Drug
CD
Controlled Drug
High Cost Medicine
High Cost Medicine
Cancer Drugs Fund
Cancer Drugs Fund
NHSE
NHS England
Homecare
Homecare
CCG
CCG

Traffic Light Status Information

Status Description

Red

Drugs for hospital use or use by a specialist within specialist centre only. Initiation and monitoring of treatment should remain under the total responsibility of the appropriate hospital clinician or specialist. These drugs should only be prescribed under the direct supervision of that clinician or specialist and are not suitable for shared care arrangements. The drug should be supplied via the hospital or specialist centre for the duration of treatment.   

Amber

These are specialist drugs which must be initiated by secondary care specialist prescribers, but with the potential to transfer prescribing to primary care within written and agreed shared care protocols and according to the agreed process for transfer of care. For these drugs, in order to ensure patient safety, some aspects of care must remain with the specialist due to their complexity e.g. monitoring of disease or drug response. Other more routine aspects can be transferred to the GP e.g. monitoring of adverse effects and supply of the medicine. The specific responsibilities of the specialist and GP are defined in the shared care agreement for each drug. Shared care agreements are still under development for some amber drugs. Until these are available, it would be expected that any shared care request from secondary care to a GP would be accompanied by written information which defines prescribing and monitoring responsibilities. The hospital specialist should also provide the GP with enough information and support to allow the safe transfer and ongoing management of prescribing into primary care.   

Green +

Drugs which should usually be initiated in secondary care, or by a specialist clinician, but can be safely maintained in primary care with very little or no monitoring required. In some cases there may be a further restriction for use outlined - these will be defined in each case.  

Green

These are defined as new and established drugs, which may be prescribed, initiated, changed or maintained on FP10 by the GP and, if appropriate, discontinued without recourse to secondary care. N.B. DRUGS NOT IDENTIFIED IN THE FORMULARY BY A RED, AMBER OR GREEN+ SYMBOL ARE CLASSIFIED AS GREEN.   

netFormulary